From Analysis:
The abstract notes that clinical presentations overlap across different myelopathy etiologies, but the mechanistic basis for this convergent phenotype is not explained. Resolving this could improve differential diagnosis and reveal common therapeutic targets. Gap type: unexplained_observation Source paper: Uncommon inflammatory/immune-related myelopathies. (2021, J Neuroimmunol, PMID:34715593)
Blood-spinal cord barrier breakdown represents mechanistic convergence point for diverse myelopathy etiologies, leading to stereotyped cascade of vascular dysfunction, protein extravasation, and secondary inflammation.
No AI visual card yet
Curated pathway diagram from expert analysis
flowchart TD
A["Diverse Spinal Cord Injury Triggers
ALS Trauma Ischemia Compression"]
B["Spinal Vascular Unit Disruption
Blood-Spinal Cord Barrier Breakdown"]
C["Pericyte Loss
Endothelial Tight Junction Degradation"]
D["VEGFA Dysregulation
Pro-Angiogenic Signaling Imbalance"]
E["Pathological Neovascularization
Leaky Immature Vessel Formation"]
F["Serum Protein Extravasation
Complement Albumin Fibrinogen Influx"]
G["Secondary Neuroinflammatory Cascade
Universal Spinal Cord Pathology"]
H["Anti-VEGFA Combination Therapy
Bevacizumab or Aflibercept"]
I["Vascular Stabilization
Pericyte Coverage Restored"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
H -.->|"normalizes VEGFA"| D
H --> I
style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style I fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7
Based on the literature describing overlapping clinical presentations across different myelopathy etiologies despite distinct underlying causes, I'll generate novel therapeutic hypotheses that address this convergent phenotype through shared mechanistic pathways.
I'll critically evaluate each hypothesis by examining the evidence base, identifying weaknesses, and proposing falsification experiments. Let me start with a systematic critique:
No clinical trials data available
Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.
No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.
Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.
High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.
Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.
Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.
No DepMap CRISPR Chronos data found for VEGFA.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No governance decisions recorded for this hypothesis.
Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.
Molecular pathway showing key causal relationships underlying this hypothesis
graph TD
C5AR1["C5AR1"] -->|mediates| complement_activation["complement activation"]
complement_activation_1["complement activation"] -->|drives| neuroinflammation["neuroinflammation"]
neuroinflammation_2["neuroinflammation"] -->|causes| myelopathy["myelopathy"]
S1PR1["S1PR1"] -->|controls| immune_cell_trafficking["immune cell trafficking"]
S1PR1_3["S1PR1"] -->|maintains| blood_spinal_cord_barrier["blood-spinal cord barrier"]
VEGFA["VEGFA"] -->|increases| vascular_permeability["vascular permeability"]
vascular_permeability_4["vascular permeability"] -->|enables| protein_extravasation["protein extravasation"]
STAT3["STAT3"] -->|mediates| astrocyte_activation["astrocyte activation"]
astrocyte_activation_5["astrocyte activation"] -->|drives| glial_scar_formation["glial scar formation"]
CX3CR1["CX3CR1"] -->|maintains| microglial_homeostasis["microglial homeostasis"]
ferroptosis["ferroptosis"] -->|causes| oligodendrocyte_death["oligodendrocyte death"]
EIF2AK3["EIF2AK3"] -->|activates| ER_stress_response["ER stress response"]
style C5AR1 fill:#ce93d8,stroke:#333,color:#000
style complement_activation fill:#81c784,stroke:#333,color:#000
style complement_activation_1 fill:#81c784,stroke:#333,color:#000
style neuroinflammation fill:#4fc3f7,stroke:#333,color:#000
style neuroinflammation_2 fill:#4fc3f7,stroke:#333,color:#000
style myelopathy fill:#ef5350,stroke:#333,color:#000
style S1PR1 fill:#ce93d8,stroke:#333,color:#000
style immune_cell_trafficking fill:#4fc3f7,stroke:#333,color:#000
style S1PR1_3 fill:#ce93d8,stroke:#333,color:#000
style blood_spinal_cord_barrier fill:#4fc3f7,stroke:#333,color:#000
style VEGFA fill:#ce93d8,stroke:#333,color:#000
style vascular_permeability fill:#4fc3f7,stroke:#333,color:#000
style vascular_permeability_4 fill:#4fc3f7,stroke:#333,color:#000
style protein_extravasation fill:#4fc3f7,stroke:#333,color:#000
style STAT3 fill:#ce93d8,stroke:#333,color:#000
style astrocyte_activation fill:#4fc3f7,stroke:#333,color:#000
style astrocyte_activation_5 fill:#4fc3f7,stroke:#333,color:#000
style glial_scar_formation fill:#4fc3f7,stroke:#333,color:#000
style CX3CR1 fill:#ce93d8,stroke:#333,color:#000
style microglial_homeostasis fill:#4fc3f7,stroke:#333,color:#000
style ferroptosis fill:#4fc3f7,stroke:#333,color:#000
style oligodendrocyte_death fill:#4fc3f7,stroke:#333,color:#000
style EIF2AK3 fill:#ce93d8,stroke:#333,color:#000
style ER_stress_response fill:#81c784,stroke:#333,color:#000
neuroinflammation | 2026-04-08 | completed
No comments yet. Be the first to comment!